CT-Derived FFR Predicts Heart Attack and Death Risk Better Than Anatomy Alone
A 7,836-patient nationwide study shows FFR-CT independently forecasts MI, cardiovascular death, and all-cause mortality over 3 years.
Summary
Coronary computed tomography angiography can now estimate fractional flow reserve (FFR-CT) — a measure of how much a narrowed artery restricts blood flow — without invasive catheterization. This nationwide UK study of nearly 8,000 patients followed for three years found that lower FFR-CT values were strongly linked to higher rates of heart attack, cardiovascular death, and all-cause death, even after accounting for traditional risk factors and the severity of artery narrowing. An FFR-CT value of 0.67 emerged as the optimal threshold separating high- from lower-risk patients. The findings suggest that adding functional blood-flow information to anatomical imaging substantially improves long-term cardiovascular risk prediction, offering clinicians a powerful non-invasive prognostic tool for managing stable coronary artery disease.
Detailed Summary
Coronary artery disease remains the leading cause of premature death and lost healthspan worldwide. For decades, cardiologists have debated whether the anatomy of a blockage — how much it narrows an artery — is enough to guide treatment, or whether functional measures of actual blood-flow impairment are needed. This study addresses that question at scale.
Researchers analyzed data from 7,836 patients (mean age 63, 37.4% women) across 27 English centers who underwent both coronary CT angiography and FFR-CT analysis using the HeartFlow platform between 2017 and 2020. FFR-CT estimates the pressure drop across a coronary stenosis using computational fluid dynamics applied to CT images — no wire, no adenosine, no catheterization laboratory required. Patients were followed for three years for myocardial infarction (MI), cardiovascular death, all-cause death, and revascularization.
The results were striking. Stenosis-specific FFR-CT was independently associated with future MI (hazard ratio 2.08–5.73), cardiovascular death (HR 1.51–3.40), and all-cause death (HR 1.01–1.58), with a clear gradient: the lower the FFR-CT, the worse the prognosis. After adjusting for established risk factors and coronary anatomy severity scores, FFR-CT ≤0.7 remained a strong predictor of MI and FFR-CT ≤0.5 predicted cardiovascular and all-cause death. Adding FFR-CT to standard risk models improved discrimination for MI or cardiovascular death (ΔC-index 0.012). An FFR-CT of 0.67 defined the optimal prognostic cut point. When stenosis-specific FFR-CT was normal (>0.8), event rates were reassuringly low at 1.5% over three years.
For longevity-focused clinicians and health-conscious individuals, this matters because cardiovascular disease is the dominant cause of age-related functional decline and death. A non-invasive test that more accurately stratifies risk enables earlier, more targeted intervention — whether lifestyle, pharmacological, or procedural — potentially extending both lifespan and healthspan. The study's scale and real-world design strengthen its applicability.
Caveats include reliance on the abstract alone, the observational design limiting causal inference, and potential selection bias since FFR-CT was clinically indicated rather than applied systematically to all CT angiography patients.
Key Findings
- FFR-CT independently predicted MI, cardiovascular death, and all-cause mortality over 3 years in 7,836 patients.
- An FFR-CT value of 0.67 was the optimal threshold for identifying patients at highest future cardiovascular risk.
- Lower FFR-CT values showed a stepwise increase in risk — severely reduced (≤0.5) carried the worst prognosis.
- Adding FFR-CT to risk-factor and anatomy models significantly improved discrimination for MI or cardiovascular death.
- Normal FFR-CT (>0.8) was associated with very low 3-year event rates (1.5% for MI or cardiovascular death).
Methodology
Prospective nationwide cohort study of 7,836 patients at 27 English sites who received coronary CT angiography plus clinically indicated HeartFlow FFR-CT analysis between 2017 and 2020, with 3-year follow-up. Outcomes included individual endpoints of MI, cardiovascular death, all-cause death, and revascularization, analyzed with Cox proportional hazards models adjusted for cardiovascular risk factors and coronary anatomy severity (CAD-RADS scoring).
Study Limitations
The summary is based on the abstract only, as the full paper was not accessible. The observational design precludes causal conclusions, and patients were selected because FFR-CT was clinically indicated, introducing possible selection bias. The 3-year follow-up, while longer than prior studies, may not capture long-term divergence in outcomes across FFR-CT strata.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: